SCHEMBL7211466

SCHEMBL7211466

CCCCCN(C)CCS

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 3/20 0.55
S1PR2 O95136 1/20 0.47
S1PR1 P21453 1/20 0.47
S1PR3 Q99500 1/20 0.47
S1PR5 Q9H228 1/20 0.47
TDP1 Q9NUW8 1/20 0.43
GGPS1 O95749 4/20 0.42
FDPS P14324 1/20 0.42
AGTR1 P30556 1/20 0.42
OPRM1 P35372 1/20 0.42
PDE3A Q14432 1/20 0.42
KDM5A P29375 3/20 0.40
KDM4C Q9H3R0 2/20 0.40
CHRM2 P08172 1/20 0.40
KDM5C P41229 1/20 0.40
KDM5B Q9UGL1 1/20 0.40
PHF8 Q9UPP1 1/20 0.39
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.36
CA12 O43570 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23390588 0.97 DNM1 (0.59) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL7902686 0.97 DNM1 (0.59) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL8427956 0.92
SCHEMBL8495114 0.90 DNM1 (0.55) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL7208783 0.90 DNM1 (0.55) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL8493299 0.87 DNM1 (0.59) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL8490335 0.87 DNM1 (0.59) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL516480 0.86 DNM1 (0.61) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL16790931 0.86 DNM1 (0.61) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL23390593 0.85 DNM1 (0.46) DNM1S1PR2S1PR1S1PR3S1PR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023205595-A2 EGFR INHIBITORS IN CANCER TREATMENT CELYN THERAPEUTICS, INC (US) 2023-10-26 WO disclosed
EP-1311475-A1 NOVEL AMINOCYCLOHEXANE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2003-05-21 EP disclosed
WO-2002014267-A1 NOVEL AMINOCYCLOHEXANE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-02-21 WO disclosed